Showing results (771-780 of 1,550) with videos related to

Sort By:
Pageof 155
Journal of Clinical Medicine|February 26, 2025
Plasma Biomarkers for Cerebral Amyloid Angiopathy and Implications for Amyloid-Related Imaging Abnormalities: A Comprehensive ReviewMo-Kyung Sin, Jeffrey L Dage, Kwangsik Nho, et al.
Research Square|November 14, 2023
miR-129-5p as a biomarker for pathology and cognitive decline in Alzheimer's diseaseSang-Won Han, Jung-Min Pyun, Paula J Bice, et al.
Biorxiv : the Preprint Server for Biology|March 27, 2026
Multi-omics characterization of vascular, neurodegenerative, and mixed neuropathology in the aging human brainAnnie J Lee, Minghua Liu, Elanur Yilmaz, et al.
Alzheimer'S Research & Therapy|September 28, 2011
Accelerating drug discovery for Alzheimer's disease: best practices for preclinical animal studiesDiana W Shineman, Guriqbal S Basi, Jennifer L Bizon, et al.
Journal of the International Neuropsychological Society : JINS|November 25, 2010
Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adultsN Maritza Dowling, Sarah Tomaszewski Farias, Bruce R Reed, et al.
Molecular Psychiatry|October 4, 2022
Brain copper may protect from cognitive decline and Alzheimer's disease pathology: a community-based studyPuja Agarwal, Scott Ayton, Sonal Agrawal, et al.
Cell Reports|June 7, 2018
Tau Activates Transposable Elements in Alzheimer's DiseaseCaiwei Guo, Hyun-Hwan Jeong, Yi-Chen Hsieh, et al.
JAMA|February 20, 2002
Participation in cognitively stimulating activities and risk of incident Alzheimer diseaseRobert S Wilson, Carlos F Mendes De Leon, Lisa L Barnes, et al.
Archives of General Psychiatry|February 7, 2007
Loneliness and risk of Alzheimer diseaseRobert S Wilson, Kristin R Krueger, Steven E Arnold, et al.
Acta Neuropathologica|June 30, 2005
Caspase-cleaved tau accumulation in neurodegenerative diseases associated with tau and alpha-synuclein pathologyJodie Newman, Robert A Rissman, Floyd Sarsoza, et al.
Pageof 155